If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmith & Nephew Regulatory News (SN.)

Share Price Information for Smith & Nephew (SN.)

Share Price is delayed by 15 minutes
Get Live Data
1,126.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (0.089%)
Market Cap: £9.52b
SN. Live PriceLast checked at - London Stock Exchange

Intraday Smith & Nephew Share Chart

Director/PDMR Shareholding

13 Aug 2025 17:08

RNS Number : 2390V
Smith & Nephew Plc
13 August 2025
 

SMITH & NEPHEW PLC

 

13 August 2025

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

1. VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2020

 

On 13 August 2025, the Company received notification of the following transactions in US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") following the vesting of awards under the Smith & Nephew Global Share Plan 2020.

 

All figures in these columns are stated to 6 decimal places where applicable.

 

 

PARTIAL VESTING OF 2023 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:

 

The awards were granted under the Global Share Plan 2020 on 11 August 2023. One third of the award vests in equal tranches over the following three years. A number of shares were sold to cover taxation obligations arising on the vesting of the awards.

 

The following relates to individuals included in the below notification:

 

Reason for the notification

Initial notification /Amendment

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Name

Smith & Nephew plc

LEI

213800ZTMDN8S67S1H61

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Description of the financial instrument, type of instrument

 

Smith & Nephew plc ordinary shares of USD 0.20 each

 

Identification code

ISIN: GB0009223206

Nature of the transaction

Partial vesting on 12 August 2025 of Conditional Share awards granted on 11 August 2023 under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability

Date of Transaction

2025 - 08 - 12

Place of Transaction

London Stock Exchange (XLON)

 

 

Name

(Position)

 

Status

Price (£)

Volume

Aggregated information

Rohit Kashyap

(President, Advanced Wound Management and Global

PDMR

13.571365

23,201 (of which 5,670 were sold and 17,531 were retained.)

N/A Single Transaction

 

 

 

Helen Barraclough

Company Secretary

Smith & Nephew plc

 

Tel: +44 (0)1923 477100

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFIRTEIVLIE
Date   Source Headline
17th Jan 20175:05 pmRNSDirector/PDMR Shareholding
12th Jan 201712:14 pmRNSDirectorate Change
3rd Jan 20174:47 pmRNSTotal Voting Rights
21st Dec 20165:01 pmRNSNotice of Results
21st Dec 20161:48 pmRNSTransaction in Own Shares
19th Dec 20165:17 pmRNSTransaction in Own Shares
16th Dec 20165:13 pmRNSTransaction in Own Shares
15th Dec 20165:38 pmRNSTransaction in Own Shares
14th Dec 20165:30 pmRNSTransaction in Own Shares
13th Dec 20165:02 pmRNSTransaction in Own Shares
12th Dec 20165:39 pmRNSTransaction in Own Shares
9th Dec 20165:33 pmRNSTransaction in Own Shares
8th Dec 20165:28 pmRNSTransaction in Own Shares
7th Dec 20165:42 pmRNSTransaction in Own Shares
6th Dec 20165:46 pmRNSTransaction in Own Shares
5th Dec 20165:48 pmRNSTransaction in Own Shares
2nd Dec 20165:31 pmRNSTransaction in Own Shares
1st Dec 20165:48 pmRNSTransaction in Own Shares
1st Dec 20163:41 pmRNSTotal Voting Rights
30th Nov 20166:05 pmRNSTransaction in Own Shares
30th Nov 20167:00 amRNSDirectorate Change
29th Nov 20165:37 pmRNSTransaction in Own Shares
28th Nov 20165:44 pmRNSTransaction in Own Shares
25th Nov 20165:19 pmRNSTransaction in Own Shares
24th Nov 20165:32 pmRNSTransaction in Own Shares
23rd Nov 20165:29 pmRNSTransaction in Own Shares
22nd Nov 20165:14 pmRNSTransaction in Own Shares
21st Nov 20165:21 pmRNSTransaction in Own Shares
18th Nov 20165:23 pmRNSTransaction in Own Shares
17th Nov 20165:42 pmRNSTransaction in Own Shares
16th Nov 20165:34 pmRNSTransaction in Own Shares
15th Nov 20165:58 pmRNSTransaction in Own Shares
14th Nov 20165:37 pmRNSTransaction in Own Shares
11th Nov 20164:25 pmRNSDirector/PDMR Shareholding
9th Nov 20165:28 pmRNSTransaction in Own Shares
7th Nov 20166:05 pmRNSTransaction in Own Shares - Replacement
7th Nov 20165:33 pmRNSTransaction in Own Shares
4th Nov 20165:48 pmRNSTransaction in Own Shares
4th Nov 20161:29 pmRNSDirector Declaration
3rd Nov 201611:00 amRNS3rd Quarter Trading Statement
1st Nov 20162:00 pmRNSTotal Voting Rights
31st Oct 20163:46 pmRNSDirector/PDMR Shareholding
26th Oct 20163:30 pmRNSDirector/PDMR Shareholding
13th Oct 20162:15 pmRNSDividend Declaration
10th Oct 20163:32 pmRNSDirector/PDMR Shareholding
3rd Oct 20163:32 pmRNSTotal Voting Rights
3rd Oct 20162:35 pmRNSNotice of Results
30th Sep 20165:56 pmRNSTransaction in Own Shares
29th Sep 20165:52 pmRNSTransaction in Own Shares
28th Sep 20165:43 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.